These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21969553)

  • 1. Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia.
    Carlson GC; Talbot K; Halene TB; Gandal MJ; Kazi HA; Schlosser L; Phung QH; Gur RE; Arnold SE; Siegel SJ
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):E962-70. PubMed ID: 21969553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1.
    Yuan Q; Yang F; Xiao Y; Tan S; Husain N; Ren M; Hu Z; Martinowich K; Ng JS; Kim PJ; Han W; Nagata KI; Weinberger DR; Je HS
    Biol Psychiatry; 2016 Aug; 80(4):312-322. PubMed ID: 26386481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.
    Jentsch JD; Trantham-Davidson H; Jairl C; Tinsley M; Cannon TD; Lavin A
    Neuropsychopharmacology; 2009 Nov; 34(12):2601-8. PubMed ID: 19641486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The schizophrenia susceptibility gene DTNBP1 modulates AMPAR synaptic transmission and plasticity in the hippocampus of juvenile DBA/2J mice.
    Orozco IJ; Koppensteiner P; Ninan I; Arancio O
    Mol Cell Neurosci; 2014 Jan; 58():76-84. PubMed ID: 24321452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.
    Talbot K; Louneva N; Cohen JW; Kazi H; Blake DJ; Arnold SE
    PLoS One; 2011 Mar; 6(3):e16886. PubMed ID: 21390302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.
    Karlsgodt KH; Robleto K; Trantham-Davidson H; Jairl C; Cannon TD; Lavin A; Jentsch JD
    Biol Psychiatry; 2011 Jan; 69(1):28-34. PubMed ID: 21035792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.
    Tang J; LeGros RP; Louneva N; Yeh L; Cohen JW; Hahn CG; Blake DJ; Arnold SE; Talbot K
    Hum Mol Genet; 2009 Oct; 18(20):3851-63. PubMed ID: 19617633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.
    Talbot K; Eidem WL; Tinsley CL; Benson MA; Thompson EW; Smith RJ; Hahn CG; Siegel SJ; Trojanowski JQ; Gur RE; Blake DJ; Arnold SE
    J Clin Invest; 2004 May; 113(9):1353-63. PubMed ID: 15124027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition deficits in mice carrying mutations of genes encoding BLOC-1 subunits pallidin or dysbindin.
    Spiegel S; Chiu A; James AS; Jentsch JD; Karlsgodt KH
    Genes Brain Behav; 2015 Nov; 14(8):618-24. PubMed ID: 26294018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.
    Weickert CS; Rothmond DA; Hyde TM; Kleinman JE; Straub RE
    Schizophr Res; 2008 Jan; 98(1-3):105-10. PubMed ID: 17961984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia.
    Takao K; Toyama K; Nakanishi K; Hattori S; Takamura H; Takeda M; Miyakawa T; Hashimoto R
    Mol Brain; 2008 Oct; 1():11. PubMed ID: 18945333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release.
    Chen XW; Feng YQ; Hao CJ; Guo XL; He X; Zhou ZY; Guo N; Huang HP; Xiong W; Zheng H; Zuo PL; Zhang CX; Li W; Zhou Z
    J Cell Biol; 2008 Jun; 181(5):791-801. PubMed ID: 18504299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression.
    Fei E; Ma X; Zhu C; Xue T; Yan J; Xu Y; Zhou J; Wang G
    J Biol Chem; 2010 Dec; 285(49):38630-40. PubMed ID: 20921223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.
    Glen WB; Horowitz B; Carlson GC; Cannon TD; Talbot K; Jentsch JD; Lavin A
    Hippocampus; 2014 Feb; 24(2):204-13. PubMed ID: 24446171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
    Numakawa T; Yagasaki Y; Ishimoto T; Okada T; Suzuki T; Iwata N; Ozaki N; Taguchi T; Tatsumi M; Kamijima K; Straub RE; Weinberger DR; Kunugi H; Hashimoto R
    Hum Mol Genet; 2004 Nov; 13(21):2699-708. PubMed ID: 15345706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Dysbindin Implicates Synaptic Vesicle Replenishment Dysregulation as a Potential Pathogenic Mechanism in Schizophrenia.
    Hu H; Wang X; Li C; Li Y; Hao J; Zhou Y; Yang X; Chen P; Shen X; Zhang S
    Neuroscience; 2021 Jan; 452():138-152. PubMed ID: 33186610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy.
    Sillitoe RV; Benson MA; Blake DJ; Hawkes R
    J Neurosci; 2003 Jul; 23(16):6576-85. PubMed ID: 12878699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbindin (DTNBP1) variants are associated with hallucinations in schizophrenia.
    Cheah SY; Lawford BR; Young RM; Morris CP; Voisey J
    Eur Psychiatry; 2015 Jun; 30(4):486-91. PubMed ID: 25697573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
    Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
    Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice.
    Saggu S; Cannon TD; Jentsch JD; Lavin A
    Schizophr Res; 2013 May; 146(1-3):254-63. PubMed ID: 23473812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.